Bioventus Inc. (BVS): Gross Profit

Annual figures by period end, from SEC filings.

$388.16M
Year ended 2025-12-31
$399.45M
Trailing 12 months to 2026-06-27
+5.4%
3-year compound annual growth
+10.7%
5-year compound annual growth
$388.23M2019-12-31: $249.21M2020-12-31: $233.52M2021-12-31: $302.71M2022-12-31: $331.08M2023-12-31: $328.19M2024-12-31: $388.23M2025-12-31: $388.16M$388.16M
2019-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$388.16M0.0%2026-03-05, From 2025-01-01
2024-12-31$388.23M+18.3%2026-03-05, From 2024-01-01
2023-12-31$328.19M-0.9%2026-03-05, From 2023-01-01
2022-12-31$331.08M+9.4%2025-03-11, From 2022-01-01
2021-12-31$302.71M+29.6%2024-03-12, From 2021-01-01
2020-12-31$233.52M-6.3%2023-03-31, From 2020-01-01
2019-12-31$249.21Mn/a2022-03-11, From 2019-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Bioventus Inc. (BVS)2025-12-31$388.16M0.0%
UFP Technologies Inc (UFPT)2025-12-31$170.41M+16.2%
AtriCure, Inc. (ATRC)2025-12-31$400.78M+15.3%
Glaukos Corp (GKOS)2025-12-31$282.76M-2.3%
NovoCure Ltd (NVCR)2025-12-31$488.47M+4.4%
Artivion, Inc. (AORT)2025-12-31$284.23M+14.2%
iRhythm Holdings, Inc. (IRTC)2025-12-31$527.25M+29.4%
Alphatec Holdings, Inc. (ATEC)2025-12-31$531.89M+25.4%
Mimedx Group, Inc. (MDXG)2025-12-31$345.62M+19.7%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗